Mike Hennessy Jr

home / authors / mike-hennessy-jr

President and CEO, MJH Life Sciences

Articles

Confident doctor and woman patient discuss test results on pad screen on appointment at oncological center. Qualified physician explain treatment plan to young female sick with cancer using tablet pc: © fizkes - stock.adobe.com

The Importance of Quality of Life in Bladder Cancer

Mike Hennessy Jr
April 5th 2024

In the April 2024 issue of Oncology Nursing News, stories focus on bladder-preserving treatment options in bladder cancer, recent FDA approvals, conference news, and embracing vicarious resilience.

Questions of Accessibility and Inclusion Continue to Draw Attention in Oncology Nursing

Questions of Accessibility and Inclusion Continue to Draw Attention in Oncology Nursing

Mike Hennessy Jr
April 19th 2022

No system can properly flourish without constant efforts to diversify, and the nursing field is no exception.

© bro vector - stockadobe.com

A Call for Resilience and Rest for the Oncology Nurse

Mike Hennessy Jr
February 16th 2022

The COVID-19 pandemic has lasted longer than most of us predicted, and extra demands and strain have been placed upon the shoulders of all those who work in health care—particularly nurses

Latest Updated Articles

ASCO Offers an ‘Eye-Opening Experience’ for Nurse Practitioners
Published: June 23rd 2024 | Updated: July 27th 2024
ASCO Offers an ‘Eye-Opening Experience’ for Nurse Practitioners
Close up of hand touching smartwatch with health app on the screen, gadget for fitness active lifestyle. © sitthiphong - stock.adobe.com
Published: April 11th 2024 | Updated: July 27th 2024
Navigating Wearable Technology in Oncology Nursing While Avoiding Data Fatigue
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Published: July 11th 2023 | Updated: July 27th 2024
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and Staging
Case Study: Recognizing the Typical Signs of Bladder Cancer
Published: July 11th 2023 | Updated: July 27th 2024
Case Study: Recognizing the Typical Signs of Bladder Cancer
FDA OKs Blinatumomab for Children, Adults with CD-19 B-ALL in Consolidation Phase
Published: June 14th 2024 | Updated: July 27th 2024
FDA OKs Blinatumomab for Children, Adults with CD-19 B-ALL in Consolidation Phase
With APP Help, Cancer Clinical Trials No Longer a ‘Last-Ditch’ Option
Published: April 28th 2024 | Updated: July 27th 2024
With APP Help, Cancer Clinical Trials No Longer a ‘Last-Ditch’ Option
© 2024 MJH Life Sciences

All rights reserved.